CD BioSciences recently announced the launch of its bio-layer interferometry (BLI) platform. This platform aims to accelerate biomolecular interaction analysis, allowing for more efficient drug discovery and development processes.   Bio-layer interferometry is a label-free, real-time, and high-throughput technique used for studying biomolecular interactions. It leverages the principle of...